Billing and Coding: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease

The information in this article contains billing, coding or other guidelines that complement the Local Coverage Determination (LCD) for MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease L36117. For single genes performed by NGS, these tests must demonstrate compliance with L38047 MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies and its accompanying billing and coding article, A54901 Billing and Coding: MolDX: Targeted and Comprehensive Genomic Profile Next-Generation Sequencing Testing in Cancer. To report Genetic Testing for BCR-ABL Negative Myeloproliferative Disease service, please submit the following claim information: Select appropriate CPT® code Enter 1 unit of service (UOS) Enter the appropriate DEX Z-Code® identifier adjacent to the CPT® code in the comment/narrative field for the following Part B claim field/types: Loop 2400 or SV101-7 for the 5010A1 837P Box 19 for paper claim Enter the appropriate DEX Z-Code® identifier adjacent to the CPT® code in the comment/narrative field for the following Part A claim field/types: Line SV202-7 for 837I electronic claim Block 80 for the UB04 claim form Select the appropriate ICD-10-CM code NOTE: When entering the DEX Z- Code® on the SV101-7 documentation field for Part B claims please do not add additional characters and/or information on the line.